CO2 Laser Phototherapy for Management of Mature Burn Scars



Status:Recruiting
Conditions:Hospital
Therapuetic Areas:Other
Healthy:No
Age Range:3 - 21
Updated:7/4/2018
Start Date:May 22, 2017
End Date:May 2023
Contact:Lynda Painting
Email:lpainting@ucdavis.edu
Phone:916-453-5085

Use our guide to learn which trials are right for you!

Randomized, Prospective, Split Scar Pilot Study to Evaluate the Efficacy of CO2 Laser Phototherapy for Management of Mature Burn Scars

Evaluate mature burn scars before and after treatment with CO2 for patients age 3-21 while
comparing the treated areas to an untreated control area in the same patient.

Laser phototherapy has gained growing acceptance and popularity for management of burn scars.
The most commonly used laser is the Carbon Dioxide (CO2) Laser. At this institution, the
investigator has used CO2 for management of Burn Scars since 2012. While the existing
literature and the investigator's anecdotal experience thus far has been positive overall,
there is no conclusive evidence to support that CO2 does indeed improve the quality of mature
burn scars

The primary objective of this study is to evaluate mature burn scars before and after
treatment with CO2 for patients age 3-21 while comparing the treated areas to an untreated
control area in the same patient.

Inclusion Criteria:

- Age 3 to 21

- Patients with mature burn scars that are at least two years old from burn injury and
that have not previously undergone CO2 laser therapy for scar revision.

- Scars in all body areas with the exception of face, genitals or hands will be
considered eligible for the study

- Entry into this study is open to pediatric patients of both genders.

- Entry into this study is open to pediatric patients of all ethnic backgrounds.

- Entry into this study is open to females of childbearing potential with a negative
urine or serum pregnancy test

Exclusion Criteria:

- Patients with scars less than 2 years old

- Patients with contraindications to laser treatment (i.e.: active acne infections/
treatment with isotretinoin, active Zoster infection)

- Patients receiving other forms of scar revision therapy such as other laser types,
steroid injections, or surgical excisions.
We found this trial at
1
site
Sacramento, California 95817
Principal Investigator: Pirko Maguina, MD
Phone: 916-453-5085
?
mi
from
Sacramento, CA
Click here to add this to my saved trials